Alkahest Company
Biopharma company founded in 2014 in San Carlos, California, acquired by Grifols in 2020. Alkahest studies plasma-derived proteins and signaling factors to treat neurological and systemic age-related diseases. Its research into the “chronokine” axis focuses on cognitive decline, inflammation, and neurodegeneration. (alkahest.com)
Investors
Headquarters:
125 Shoreway Road, Suite D, San Carlos, CA 94070, United States
Employee Number:
48
Founded Date:
2014
Estimated Revenue:
No public info